Xencor, Inc.
Nasdaq XNCR · Pasadena, CA
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
Xencor, Inc. is a clinical trial sponsor based in Pasadena, CA, listed as Nasdaq XNCR. It has 8 active clinical trials with 1,375 planned participants, across 16 therapeutic areas. Since 2021 it has completed 9 trials and stopped 6 early.
Trial track record · since 2021
Financials · Nasdaq XNCR
Pipeline · 8 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Xencor, Inc
Xencor, Inc is lead sponsor of 8 active clinical trials on ClinicalTrials.gov, with 1,375 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 9 trials and stopped 6 early.
Xencor, Inc is based in Pasadena, CA and is listed as Nasdaq XNCR. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Xencor, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Xencor, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.